1.16
Precedente Chiudi:
$1.13
Aprire:
$1.13
Volume 24 ore:
693.27K
Relative Volume:
0.39
Capitalizzazione di mercato:
$435.83M
Reddito:
$106.34M
Utile/perdita netta:
$-74.66M
Rapporto P/E:
-1.2211
EPS:
-0.95
Flusso di cassa netto:
$-46.12M
1 W Prestazione:
+5.45%
1M Prestazione:
-0.85%
6M Prestazione:
-35.56%
1 anno Prestazione:
-55.56%
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
2 TOWER PLACE, SOUTH SAN FRANCISCO
Confronta LAB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LAB
Standard Biotools Inc
|
1.16 | 435.83M | 106.34M | -74.66M | -46.12M | -0.95 |
![]()
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-02-27 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2024-04-16 | Iniziato | TD Cowen | Buy |
2024-04-04 | Iniziato | Jefferies | Buy |
2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
Positive week for Standard BioTools Inc. (NASDAQ:LAB) institutional investors who lost 58% over the past year - simplywall.st
Vanguard Group Inc. Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 11,070 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
40,166 Shares in Standard BioTools Inc. (NASDAQ:LAB) Acquired by KLP Kapitalforvaltning AS - Defense World
Major Improvements In Standard BioTools Inc (LAB) Stock Need To Be Considered - stocksregister.com
Commonwealth Equity Services LLC Sells 51,993 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies - marketscreener.com
Fluidigm stock plunges to 52-week low of $0.98 amid sharp decline - Investing.com UK
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
HighTower Advisors LLC Has $162,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Swiss National Bank - Defense World
What Will Standard BioTools Inc (NASDAQ: LAB) Be Like In 2025 - Stocks Register
Charles Schwab Investment Management Inc. Sells 112,434 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Bank of New York Mellon Corp Reduces Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools at KeyBanc Forum: Strategic Moves in Plasma Proteomics By Investing.com - Investing.com Canada
STANDARD BIOTOOLS INC. SEC 10-K Report - TradingView
Standard BioTools Inc. (LAB) reports earnings - qz.com
Rhumbline Advisers Sells 10,975 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock - Investing.com India
Casdin Partners master fund buys $5.13 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $5.13 million in Standard BioTools stock - Investing.com
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Biochips Market Generated Opportunities, Future Scope 2025-2032 | PerkinElmer, Inc., Fluidigm Corporation, Illumina - openPR
Q1 Earnings Forecast for Standard BioTools Issued By KeyCorp - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St
ARK Investment Management LLC Lowers Stake in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Participate in Upcoming Investor Conferences -February 27, 2025 at 04:02 pm EST - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Hits Estimates - MarketBeat
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges - TipRanks
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard BioTools downgraded to Sector Weight from Overweight at KeyBanc - TipRanks
Standard BioTools Sets March Investor Conference Schedule: What Financial Updates Might Be Revealed? - StockTitan
Standard BioTools Shares Fall After Downgrade From KeyBanc -February 27, 2025 at 01:59 pm EST - Marketscreener.com
Standard BioTools stock downgraded at KeyBanc (LAB:NASDAQ) - Seeking Alpha
Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript - Insider Monkey
KeyBanc Downgrades Standard BioTools to Sector Weight From Overweight, Removes $4 Price Target - Marketscreener.com
KeyBanc cuts Standard BioTools stock rating on revenue concerns - Investing.com India
KeyBanc cuts Standard BioTools stock rating on revenue concerns By Investing.com - Investing.com South Africa
Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Standard BioTools: Q4 Earnings Snapshot - CTPost
Standard BioTools reports Q4 EPS (9c), consensus (3c) - TipRanks
Standard BioTools Reports 2024 Financial Results - TipRanks
Buy Rating for Standard BioTools: Balancing Challenges with Strategic Growth Initiatives - TipRanks
Standard BioTools: Q4 Earnings Snapshot -February 26, 2025 at 06:53 pm EST - Marketscreener.com
Earnings call transcript: Standard BioTools Q4 2024 misses forecasts, stock dips - Investing.com
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools Reports 2024 Financial Results and Strategic Outlook - TipRanks
Can Standard BioTools' Massive $90M Cost Cuts Offset Declining Revenue? - StockTitan
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):